<?xml version="1.0" encoding="UTF-8"?>
<p>AQP2 was detected to be down-regulated in LPS-induced HK-2 cells in comparison with the cells in the control group (
 <xref ref-type="fig" rid="F0003">Figure 3(A,B)</xref>, 
 <italic>p</italic> &lt; 0.01). AQP2 was up-regulated in LPS-induced HK-2 cells after the transfection of pcDNA3.1-AQP2 (
 <xref ref-type="fig" rid="F0003">Figure 3(C,D)</xref>, 
 <italic>p</italic> &lt; 0.001). The LPS + pcDNA3.1-AQP2 group obtained less apoptotic cells than the LPS + pcDNA3.1 group (
 <xref ref-type="fig" rid="F0003">Figure 3(E)</xref>, 
 <italic>p</italic> &lt; 0.01). Furthermore, Bax and cleaved caspase-3 were reduced, and Bcl-2 was increased in the LPS + pcDNA3.1-AQP2 group compared to the LPS + pcDNA3.1 group (
 <xref ref-type="fig" rid="F0003">Figure 3(F)</xref>, 
 <italic>p</italic> &lt; 0.05). The expression levels of TNF-α, IL-1β, and IL-6 also declined in the LPS + pcDNA3.1-AQP2 group compared to the LPS + pcDNA3.1 group (
 <xref ref-type="fig" rid="F0003">Figure 3(G–I)</xref>, 
 <italic>p</italic> &lt; 0.05). From the above, AQP2 can inhibit LPS-induced apoptosis and inflammatory response in HK-2 cells.
</p>
